Atlas Trials

An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies

Clinical trial NCT01677780 · COMPLETED

Trial details

NCT number
NCT01677780
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Myelogenous Leukemia, Chronic, Neoplasms, Myelogenous Leukemia, Acute
Start date
2012-11-28
Primary completion
2017-06-26
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.